The 2025 CDC data reporting historic low US infant mortality prompts an essential question for clinicians and policymakers: Why do clinical achievements not translate into global competitiveness? Evidence points to three actionable insights. First, prenatal care remains fragmented across insurance and geographic divides, limiting preventive intervention. Second, racial and socioeconomic disparities—evidenced historically by Black infant mortality rates two to three times higher than white peers—persist despite overall improvements. Third, the American healthcare system prioritizes acute neonatal intervention over prenatal prevention and maternal health optimization. These structural barriers explain why the US lags nations with more integrated, equity-centered maternal health systems. Addressing them requires reform beyond clinical innovation: systemic investment in access, health equity, and preventive care infrastructure.
Was this article helpful?
